Lipella Pharmaceuticals Inc
LIPO2.360USD
-0.345-12.75%
Market hours （ET）Quotes delayed by 15 min
USD0.000Pre-market (ET)
6.02MMarket Cap
LossP/E TTM
Lipella Pharmaceuticals Inc
2.360
-0.345-12.75%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q1
FY2021Q4
Operating cash flows (indirect method)
Cash flow from continuing operating activities
-2.71%-1.43M
-36.10%-990.41K
5.26%-653.10K
-40.25%-918.79K
-28.80%-1.39M
-214.27%-727.71K
---689.36K
---655.11K
-54.12%-1.08M
50.85%-231.56K
---699.43K
---471.17K
Net income from continuing operations
-9.63%-1.31M
-109.28%-1.44M
-9.15%-1.44M
39.03%-938.15K
-11.61%-1.19M
-89.29%-688.88K
---1.32M
---1.54M
-44.70%-1.07M
5.40%-363.93K
---737.95K
---384.69K
Operating gains losses
902.78%722.00
-0.28%721.00
-24.95%722.00
--1.37K
--72.00
--723.00
--962.00
----
----
----
----
----
Other non-cash items
-100.00%0.00
--4.00
-100.00%-3.00
---650.00
--200.65K
100.00%0.00
--121.20K
----
----
96.49%-2.00K
----
---57.04K
Change in working capital
80.14%-120.33K
1035.22%369.87K
92.88%411.39K
-250.01%-62.03K
-170.29%-605.99K
-130.50%-39.55K
--213.29K
--41.35K
-13.09%-224.20K
516.19%129.66K
---198.24K
---31.16K
-Change in receivables
97.50%-918.00
-357.19%-53.63K
116.95%4.25K
-39.91%33.60K
-223.44%-36.65K
118.35%20.85K
---25.10K
--55.92K
--29.69K
---113.66K
--0.00
--0.00
-Change in prepaid expenses
77.51%-165.02K
231.49%347.48K
851.32%163.84K
-114.76%-22.13K
-488.96%-733.60K
243.76%104.82K
--17.22K
--149.98K
185.35%188.60K
142.31%30.49K
---220.97K
---72.07K
-Change in other current liabilities
3665.45%21.69K
73.43%-397.00
-102.78%-141.00
-101.64%-138.00
-42.23%576.00
88.19%-1.49K
--5.08K
--8.43K
110.78%997.00
-361.99%-12.65K
--473.00
--4.83K
Cash from non-recurring investing activities
Cash from operating activities
-2.71%-1.43M
-36.10%-990.41K
5.26%-653.10K
-40.25%-918.79K
-28.80%-1.39M
-214.27%-727.71K
---689.36K
---655.11K
-54.12%-1.08M
50.85%-231.56K
---699.43K
---471.17K
Investing cash flow
Net cash from continuing investing activities
----
----
----
----
----
--0.00
--14.43K
----
----
----
----
----
Capital expenditures
----
----
----
----
----
--0.00
--14.43K
----
----
----
----
----
Net cash flow from disposal of fixed assets
----
----
----
----
----
--0.00
--14.43K
----
----
----
----
----
Net cash flow from investment products
----
----
----
----
----
----
--0.00
--0.00
100.00%0.00
100.00%0.00
---300.00K
---300.55K
Cash from non-current investing activities
Net cash flow from investing activities
--0.00
----
----
----
--0.00
--0.00
---14.43K
--0.00
100.00%0.00
100.00%0.00
---300.00K
---300.55K
Financing cash flow
Cash flow from continuous financing activities
1633.14%3.47M
13.03%1.82M
--820.33K
100.00%0.00
900.00%200.00K
-69.24%1.61M
--0.00
---250.00K
---25.00K
233138.20%5.24M
--0.00
--2.25K
Net cash flow from debt Issuance/repayment
----
----
----
----
100.00%0.00
-100.00%0.00
--0.00
---250.00K
---25.00K
--275.00K
--0.00
--0.00
Net cash flow from common stock issuance/repurchase
1633.14%3.47M
--1.82M
--820.33K
--0.00
--200.00K
----
----
----
----
220894.21%4.96M
----
--2.25K
Proceeds from issuance of warrants
----
----
----
----
----
--1.61M
----
----
----
----
----
----
Net cash from non-recurrent financing activities
Net cash from financing activities
1633.14%3.47M
13.03%1.82M
--820.33K
100.00%0.00
900.00%200.00K
-69.24%1.61M
--0.00
---250.00K
---25.00K
233138.20%5.24M
--0.00
--2.25K
Net cash flow
Beginning cash balance
-33.67%2.18M
-43.82%1.35M
-61.89%1.19M
-47.61%2.11M
-35.69%3.29M
1999.68%2.41M
--3.11M
--4.02M
262.26%5.12M
-94.74%114.77K
--1.41M
--2.18M
Current period cash flow changes
271.67%2.04M
-5.97%831.13K
123.76%167.23K
-1.51%-918.79K
-7.75%-1.19M
-82.35%883.89K
---703.80K
---905.11K
-10.36%-1.10M
750.70%5.01M
---999.43K
---769.47K
Ending cash balance
100.68%4.23M
-33.67%2.18M
-43.82%1.35M
-61.89%1.19M
-47.61%2.11M
-35.69%3.29M
--2.41M
--3.11M
869.77%4.02M
262.26%5.12M
--414.40K
--1.41M
Free cash flow
----
----
----
----
----
-214.27%-727.71K
---703.80K
---655.11K
-54.12%-1.08M
50.85%-231.56K
---699.43K
---471.17K
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
